about
Targeted therapies in sarcomas: challenging the challengeEmerging pharmacotherapies for neurodevelopmental disordersPheochromocytomas and Paragangliomas: Clinical and Genetic ApproachesEliminating barriers to personalized medicine: learning from neurofibromatosis type 1Tumors of the neural crest: Common themes in development and cancerDifferential diagnoses of overgrowth syndromes: the most important clinical and radiological disease manifestationsMouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studiesAn update on the genetics of pheochromocytomaPreclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imagingA machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastomaNeurofibromatosis: A Review of NF1, NF2, and Schwannomatosis.Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature.Hereditary genodermatoses with cancer predispositionOral metastasis of metaplastic breast carcinoma in a patient with neurofibromatosis 1.Prevalence of scoliosis in Williams-Beuren syndrome patients treated at a regional reference center.Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemiaTAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.Concurrence of linear epidermal nevus and nevus flammeus in a man with optic pathway glioma: coincidence or phacomatosis?In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.Carbon dioxide laser treatment of cutaneous neurofibromasDiffuse plexiform neurofibroma of the back: report of a case.Legius syndrome: case report and review of literature.Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.Metaplastic breast cancer in a patient with neurofibromatosis.Extraskeletal Chondroma of the Gluteal Region Along with Sporadic Neurofibroma - An Unusual Presentation.A rare case of primary congenital glaucoma in combination with neurofibromatosis 1: a case reportPerioperative management of neurofibromatosis type 1.New developments in mammalian target of rapamycin inhibitors for the treatment of sarcomaPTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formationHomozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD)A high-throughput molecular data resource for cutaneous neurofibromas.Lisch and the Importance of His Nodules.Eponymous signs in dermatology.Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST.A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.Multifocal Head and Neck Neurofibromas with Osseous Abnormalities and Muscular Hypoplasia in a Child with Neurofibromatosis: Type I.Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.Neurofibromatosis type 1 and Chiari type 1 malformation: A case report and literature review of a rare association
P2860
Q21285014-E39B4DCC-A071-424F-9FA9-7669F76D041AQ24619170-5D79E9FF-618D-42B2-BFD2-1668AEB87EFBQ26782841-B8162C11-DC9D-47BD-9744-8348CE4C4CABQ26828988-1442631E-AF27-43DD-8FBC-5CB099E1D818Q26864763-05A65327-C403-4276-AEFE-4ABD9BEB986FQ27002915-16A64E84-E2DD-4F58-BF4F-656ACC898633Q27008537-2B17BCF7-4C02-49F8-B6C9-02F470001BBBQ27024087-EEE1A1CF-E7FA-497E-8194-42F3DA341216Q28305337-26A43459-EB59-4F1D-9505-8F2ACB32F3ABQ30274830-65F739B7-38F2-4FA8-AB5D-DBF77553FF74Q30355245-75EB6016-DD1C-41FC-B8F2-925FFEEF3AF9Q30435359-0962D9E2-BD0A-451C-B667-D1836B600D72Q30470596-C59A16CA-1A83-4D6C-A771-B79F97CFB510Q33614585-1E4381B6-58A1-4B90-9D83-45E47A16EB2EQ33846320-7C6B14EC-0EDD-40D6-9879-381C14FF310FQ33889342-D49741AA-625C-4608-8AB6-CD7D7C7EE4EFQ34105259-1F0DA41A-F099-41CE-B8B7-57B665103563Q34239338-CC0BEA56-70A7-4448-95C0-9AF2519AE4D7Q34488339-3CABE5D0-B33B-4C47-B846-A07BE4512D71Q34498185-554F3514-4B5B-4EF5-85E9-79D372FC3E51Q35053683-7FCF30D1-F84B-47E6-948D-376A6D012E33Q35068740-7A786A58-5651-4A3B-B569-9277479937FBQ35133489-44604FFB-53E4-4A38-BE70-1710AD642AF7Q35355402-4A812AFF-7687-484C-9AB4-A125F7C90265Q35792354-2B8DE77C-C150-4638-89D8-9FD501190A0FQ35826563-3A1F4912-24F6-421A-92AA-243EFF0DAEE3Q36071038-9CB7A416-D11C-4375-A855-4C058A0922E4Q36144084-1ECE2E96-5C9D-41E6-9F51-1BFAFB990DE0Q36190648-6745F2CE-6169-4097-A0AE-96541F7CBAB3Q36298172-B430872F-2295-4D35-8887-4384AF2D5647Q36337089-BAFF6F8B-9EE4-4ED6-91C4-5144EC2C562DQ36343064-3561499E-86ED-4A18-B0CC-1FA43CC13D0EQ36345004-EB68D33F-D963-49BB-8D8B-5D89AAA7DBEBQ36420592-B66C7168-5F6D-4D8E-9DAC-95E9AECE45CFQ36516082-41877041-80A1-4CC9-A6F7-2F2CB86C979FQ36535847-B0D789FD-0CB4-4399-B1D1-5D504FE472BDQ36663582-E45337E9-92D5-4130-9F83-5F54CE0F647DQ37038284-1FFBA243-19C3-4297-9C50-86890B07D94FQ37120427-EFE76FA6-40E2-493C-B449-1E247682362DQ37126116-F2C82F90-469D-48A1-95D9-7CAD8F2B8276
P2860
description
im Juli 2009 veröffentlichter wissenschaftlicher Artikel
@de
наукова стаття, опублікована в липні 2009
@uk
name
Neurofibromatosis type 1
@en
type
label
Neurofibromatosis type 1
@en
prefLabel
Neurofibromatosis type 1
@en
P2093
P2860
P1476
Neurofibromatosis type 1
@en
P2093
Bruce R Korf
Kevin P Boyd
P2860
P304
1-14; quiz 15-6
P356
10.1016/J.JAAD.2008.12.051
P407
P577
2009-07-01T00:00:00Z